Australians with cancer will receive more personalised and tailored care through the new Precision Care Clinic at Prince of Wales Hospital.
The Precision Care Clinic has brought together a team of Australian experts with international recognition to lead this game-changing research program.
The clinic will support the rapid adoption of precision medicine research into routine public healthcare.
Precision medicine is an emerging scientific area which treats patients based on their individual makeup and genes.
It takes into consideration their long-recognised clinical, lifestyle and environmental factors, strategically matching the right treatment or clinical trial to the right patient.
Cancer doctors and patients from across Australia will be able to seamlessly incorporate genomic results into care plans.
This will allow them to comprehensively consider all current and emerging treatment options and their potential implications, including targeted therapy, clinical trials and cancer risk management.
The clinic has been carefully designed to support healthcare professionals currently facing gaps and challenges in providing precision care to their patients.
This project is a partnership between UNSW School of Population Health; Prince of Wales Hospital & South Eastern Sydney Local Health District; Omico; Cancer Voices NSW; Australian Catholic University; University of Sydney; and Macquarie University, to integrate precision medicine into routine cancer care.
The initiative is part of a five-year commitment from the Australian Government to establish multiple precision care clinics across Australia through a $5.8 million grant from the Medical Research Future Fund Rapid Applied Research Translation scheme.
Quotes attributable to Federal Minister for Health Mark Butler:
“The opening of this new facility is a major step towards changing the way we approach cancer diagnosis, treatment, and prevention.
“This innovative cancer clinic will combine genomic research and implementation science to ensure the benefits of precision medicine are effectively translated into improved health outcomes for people with cancer across Australia.”